In line with our in vitro findings, CAR-IL-15-pNK cells demonstrated significantly enhanced eradication of multiple myeloma cells compared to GFP-IL-15-pNK and UT-pNK controls (Figure 2H). Here, IL15 is linked to plasma cell myeloma.